WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target

Benzinga Newsdesk www.benzinga.com Negative 83.5%

Neg 83.5% Neu 0% Pos 0%

WBB Securities analyst Karen Sterling downgrades Turn Therapeutics (NASDAQ:TTRX) from Hold to Sell and announces $10 price target.